Short answer
West Pharmaceutical Services (WST) filed an 8-K current report with the SEC on April 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Investor presentation attached as Exhibit 99.2, providing supplemental materials from the company’s call.
West Pharmaceutical Services 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Investor presentation attached as Exhibit 99.2, providing supplemental materials from the company’s call
- Materials also available through West Pharmaceutical Services’ investor website
- Filing furnishes information under Item 2.02, indicating earnings-related disclosure for fiscal year 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other West Pharmaceutical Services 8-K filings
Get the next WST 8-K as it lands
Follow WST for push alerts, or ask the research agent what this filing means.